X0202 4 2006-01-06 0 0001318310 ev3 Inc. b#3bbbbb 0001238620 CORBETT JAMES 2 GOODYEAR IRVINE CA 92618 1 1 0 0 Pres. & CEO Common Stock 2006-01-06 4 A 0 3572 A 129793 D Stock Option 13.23 2006-01-06 4 A 0 7620 A 2012-01-02 Common Stock 7620 7620 D Stock Option 14.7 2006-01-06 4 A 0 23814 A 2012-01-14 Common Stock 23814 23814 D Stock Option 9.14 2006-01-06 4 A 0 4763 A 2012-06-04 Common Stock 4763 4763 D Stock Option 6.47 2006-01-06 4 A 0 1905 A 2013-05-22 Common Stock 1905 1905 D Stock Option 8.76 2006-01-06 4 A 0 1905 A 2014-05-20 Common Stock 1905 1905 D Stock Option 8.4 2006-01-06 4 A 0 1905 A 2015-05-26 Common Stock 1905 1905 D Received in exchange for 3,572 shares of Micro Therapeutics, Inc. common stock in connection with the merger between Micro Therapeutics, Inc. and a wholly-owned subsidiary of the issuer (the "Merger"). On the effective date of the Merger, the closing price of Micro Therapeutics, Inc. common stock was $6.64 per share, and the closing price of ev3, Inc. common stock was $14.00 per share. The issuer's board of directors approved all issuances to Reporting Person that are subject of this report. Includes 100,000 shares issued 12/29/05 bunder the issuer's Amended and Restated 2005 2005 Stock Incentive Plan. Such shares vest over time and are subject to forfeiture until vested. Received in the Merger in exchange for an option to purchase 16,000 shares of Micro Therapeutics, Inc. common stock for $6.30 per share. Vesting continued as originally set and issuer options are fully vested. Received in the Merger in exchange for an option to purchase 50,000 shares of Micro Therapeutics, Inc. common stock for $7.00 per share. Vesting continued as originally set and issuer options are fully vested. Received in the Merger in exchange for an option to purchase 10,000 shares of Micro Therapeutics, Inc. common stock for $4.35 per share. Vesting continued as originally set and issuer options are fully vested. Received in the Merger in exchange for an option to purchase 4,000 shares of Micro Therapeutics, Inc. common stock for $3.08 per share, which provided for vesting in the amount of 25% on May 22, 2003, with the remaining vesting in three equal annual installments thereafter. Vesting continues as originally scheduled. Received in the Merger in exchange for an option to purchase 4,000 shares of Micro Therapeutics, Inc. common stock for $4.17 per share, which provided for vesting in the amount of 25% on May 22, 2004, with the remaining vesting in three equal annual installments thereafter. Vesting continues as originally scheduled. Received in the Merger in exchange for an option to purchase 4,000 shares of Micro Therapeutics, Inc. common stock for $4.00 per share, which provided for vesting in the amount of 25% on May 26, 2004, with the remaining vesting in three equal annual installments thereafter. Vesting continues as originally scheduled. /s/ L. Cecily Hines, Attorney-in-Fact 2006-01-10